Nara, Japan

Toshiki Murata

This inventor holds 2 USPTO granted patents. Top assignees: Ciba Geigy Japan Limited, Japat Limited. Active years: 1997-1998.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Toshiki Murata. Retrieved from https://idiyas.com/inventor/toshiki-murata-y5li1vw7

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 6.9

ph-index = 2

Forward Citations = 18(Granted Patents)


Location History:

  • Nara-ken, JP (1997)
  • Ikoma, JP (1998)

Company Filing History:


Years Active: 1997-1998

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Toshiki Murata

Introduction

Toshiki Murata is a notable inventor based in Nara-ken, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of endothelin receptor antagonists. With a total of two patents to his name, Murata's work has had a meaningful impact on medical science.

Latest Patents

Murata's latest patents focus on endothelin receptor antagonists. These antagonists play a crucial role in the treatment of various cardiovascular diseases. His innovative approach has opened new avenues for therapeutic interventions.

Career Highlights

Throughout his career, Toshiki Murata has worked with prominent companies such as Ciba Geigy Japan Limited and Japat Limited. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking research in his field.

Collaborations

Murata has collaborated with esteemed colleagues, including Thomas Pitterna and Thomas Fruh. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Toshiki Murata's contributions to the field of pharmaceuticals through his patents and collaborations highlight his importance as an inventor. His work continues to influence the development of new treatments for cardiovascular diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…